
Cognex Pharma Limited
Manufactures and exports pharmaceutical, veterinary, and cosmetic products, as well as chemicals and surgical equipment.
Manufactures and exports pharmaceutical, veterinary, and cosmetic products, as well as chemicals and surgical equipment.
Cognex Pharma Limited (CPL) is a Public Limited Indian Non-Government Company incorporated in India on 14 May 1980 and has a history of 44 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.30 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.44 Cr.
Satyanarayana Gangavaram, Bhaskar Poralla, Sampath Vijayaraghavan, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24230TG1980PLC002680
002680
Public Limited Indian Non-Government Company
14 May 1980
29 Sep 2018
31 Mar 2018
Unlisted
Roc Hyderabad
Cognex Pharma Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satyanarayana Gangavaram ![]() | Managing Director | 16-Oct-1989 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhaskar Poralla ![]() | Director | 16-Oct-1989 | Current |
Sampath Vijayaraghavan ![]() | Director | 27-Oct-2005 | Current |
Bhaskar Atla ![]() | Additional Director | 28-Mar-2018 | Current |
Naga Chanda ![]() | Additional Director | 10-Jan-2018 | Current |
Cognex Pharma Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.66% increase in profit. The company's net worth dipped by a decrease of 2.92%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Cognex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Bhaskar Atla and Naga Chanda are mutual person
Bhaskar Atla is a mutual person
₹4.44 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
23 May 2003 | Punjab National Bank | ₹1.50 M | Open |
22 Mar 2003 | Punjab National Bank | ₹3.59 Cr | Open |
07 Aug 1995 | State Bank Of India | ₹1.52 M | Open |
04 Dec 1991 | A.P.S.F.C. Chirag Ali Lane | ₹1.79 M | Open |
17 May 1990 | Andhra Bank | ₹3.51 M | Open |
Unlock and access historical data on people associated with Cognex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cognex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cognex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cognex Pharma Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Cognex Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.
Bhaskar Reddy Atla was appointed as a Additional Director was appointed as a Additional Director on 28 Mar 2018 & has been associated with this company since 7 years 15 days .
Naga Raju Chanda was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2018 & has been associated with this company since 7 years 3 months .
A charge with Punjab National Bank of Rs. 3.59 Cr registered on 22 Mar 2003 with Charge ID 90117810 was modified on 07 Jul 2007.
Sampath Vijayaraghavan was appointed as a Director was appointed as a Director on 27 Oct 2005 & has been associated with this company since 19 years 5 months .
Cognex Pharma Limited was incorporated on 14 May 1980.
The authorized share capital of Cognex Pharma Limited is ₹ 2.30 Cr and paid-up capital is ₹ 5.00 M.
Currently 5 directors are associated with Cognex Pharma Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cognex Pharma Limited is Flat No.303 Prithvi Style Homes Kamalanagar, Ecil India, Hyderabad, Telangana, 500062.
The corporate identification number (CIN) of Cognex Pharma Limited is U24230TG1980PLC002680 and the company number is 002680 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2018 indicates that The net worth of Cognex Pharma Limited has experienced an downturn of -2.92%.
As per the financial statements for fiscal Year 2018, The total open charges for Cognex Pharma Limited amount to ₹ 4.44 Cr.
The most recent Balance Sheet for Cognex Pharma Limited was filed with the ROC on 31 Mar 2018.
Search company & director profiles for free and gain access to critical business data.